Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection

Journal of Infection

Volumn 69, Issue 1, 2014, Pages 88-95

  Kim, Soo Jung ^a,b,c   Lee, Jinwoo ^a,b   Cho, Young Jae ^a,c   Park, Young Sik ^a,b   Lee, Chang Hoon ^a,b   Yoon, Ho Il ^a,c   Lee, Sang Min ^a,b   Yim, Jae Joon ^a,b   Lee, Jae Ho ^a,c   Yoo, Chul Gyu ^a,b   Lee, Choon Taek ^a,c   Kim, Young Whan ^a,b   Han, Sung Koo ^a,b   Kim, Hong Bin ^a,c   Park, Jong Sun ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Immunocompromised patients; Pneumocystis jirovecii pneumonia; Prognostic factor

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; NITROGEN; UREA;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; BACTEREMIA; CHEMOTHERAPY; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CYTOMEGALOVIRUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LUNG ALVEOLUS OXYGEN TENSION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEUTROPHIL COUNT; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; SCREENING; SMOKING; UREA NITROGEN BLOOD LEVEL; AGED; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; MIDDLE AGED; PATHOLOGY; PNEUMONIA, PNEUMOCYSTIS; RADIOGRAPHY;

ADULT; AGED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 84902009743     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.02.015     Document Type: Article

References (30)

1. Thomas C.F., Limper A.H. Pneumocystis pneumonia. N Engl J Med 2004, 350:2487-2498.
2. Festic E., Gajic O., Limper A.H., Aksamit T.R. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 2005, 128:573-579.
3. Monnet X., Vidal-Petiot E., Osman D., Hamzaoui O., Durrbach A., Goujard C., et al. Critical care management and outcome of severe pneumocystis pneumonia in patients with and without HIV infection. Crit Care 2008, 12:R28.
4. Bollee G., Sarfati C., Thiery G., Bergeron A., de Miranda S., Menotti J., et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest 2007, 132:1305-1310.
5. Benfield T.L., Helweg-Larsen J., Bang D., Junge J., Lundgren J.D. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest 2001, 119:844-851.
6. Bang D., Emborg J., Elkjaer J., Lundgren J.D., Benfield T.L. Independent risk of mechanical ventilation for AIDS-related Pneumocystis carinii pneumonia associated with bronchoalveolar lavage neutrophilia. Respir Med 2001, 95:661-665.
7. Azoulay E., Parrot A., Flahault A., Cesari D., Lecomte I., Roux P., et al. AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia. Am J Respir Crit Care Med 1999, 160:493-499.
8. Benson C.A., Spear J., Hines D., Pottage J.C., Kessler H.A., Trenholme G.M. Combined APACHE II score and serum lactate dehydrogenase as predictors of in-hospital mortality caused by first episode Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 1991, 144:319-323.
9. Alves C., Nicolas J.M., Miro J.M., Torres A., Agusti C., Gonzalez J., et al. Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J 2001, 17:87-93.
10. Mason G.R., Hashimoto C.H., Dickman P.S., Foutty L.F., Cobb C.J. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989, 139:1336-1342.
11. Walzer P.D., Evans H.E., Copas A.J., Edwards S.G., Grant A.D., Miller R.F. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008, 46:625-633.
12. Fei M.W., Kim E.J., Sant C.A., Jarlsberg L.G., Davis J.L., Swartzman A., et al. Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 2009, 64:1070-1076.
13. Hardak E., Neuberger A., Yigla M., Berger G., Finkelstein R., Sprecher H., et al. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection. Respirology 2012, 17:681-686.
14. Roblot F., Godet C., Le Moal G., Garo B., Faouzi Souala M., Dary M., et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002, 21:523-531.
15. Matsumura Y., Ito Y., Iinuma Y., Yasuma K., Yamamoto M., Matsushima A., et al. Quantitative real-time PCR and the (1->3)-beta-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2012, 18:591-597.
16. Coyle P.V., McCaughey C., Nager A., McKenna J., O'Neill H., Feeney S.A., et al. Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem. J Med Microbiol 2012, 61:1009-1015.
17. Vanhems P., Toma E. Evaluation of a prognostic score. Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1995, 107:107-112.
18. Asai N., Motojima S., Ohkuni Y., Matsunuma R., Nakasima K., Iwasaki T., et al. Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?. Multidiscip Respir Med 2012, 7:2.
19. Speich R., Opravil M., Weber R., Hess T., Luethy R., Russi E.W. Prospective evaluation of a prognostic score for Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1992, 102:1045-1048.
20. Ewig S., Bauer T., Schneider C., Pickenhain A., Pizzulli L., Loos U., et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 1995, 8:1548-1553.
21. Kovacs J.A., Masur H. Evolving health effects of pneumocystis: one hundred years of progress in diagnosis and treatment. J Am Med Assoc 2009, 301:2578-2585.
22. Barlow G., Nathwani D., Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 2007, 62:253-259.
23. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
24. Beier K., Eppanapally S., Bazick H.S., Chang D., Mahadevappa K., Gibbons F.K., et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of "normal" creatinine. Crit Care Med 2011, 39:305-313.
25. Casaer M.P., Mesotten D., Schetz M.R. Bench-to-bedside review: metabolism and nutrition. Crit Care 2008, 12:222.
26. Mikaelsson L., Jacobsson G., Andersson R. Pneumocystis pneumonia - a retrospective study 1991-2001 in Gothenburg. Swed J Infect 2006, 53:260-265.
27. Fox B.C., Sollinger H.W., Belzer F.O., Maki D.G. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990, 89:255-274.
28. Green H., Paul M., Vidal L., Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007, CD005590.
29. Bozzette S.A., Sattler F.R., Chiu J., Wu A.W., Gluckstein D., Kemper C., et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1990, 323:1451-1457.
30. Fan L.C., Lu H.W., Cheng K.B., Li H.P., Xu J.F. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One 2013, 8:e73099.